Cargando…
Open‐label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol‐induced refractory leukoderma
Rhododendrol (RD), 4‐(4‐hydroxyphenyl)‐2‐butanol, inhibits melanin synthesis and had been used in skin‐whitening cosmetic products until 2013. However, some individuals developed leukoderma on the skin where RD had been applied and have suffered from refractory depigmentation even after discontinuin...
Autores principales: | Fukaya, Saki, Kamata, Masahiro, Kasanuki, Tomoko, Yokobori, Makoto, Takeoka, Shintaro, Hayashi, Kotaro, Tanaka, Takamitsu, Fukuyasu, Atsuko, Ishikawa, Takeko, Ohnishi, Takamitsu, Iimuro, Satoshi, Tada, Yayoi, Watanabe, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283075/ https://www.ncbi.nlm.nih.gov/pubmed/30156328 http://dx.doi.org/10.1111/1346-8138.14634 |
Ejemplares similares
-
Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
por: Ito, Makoto, et al.
Publicado: (2020) -
Biochemical Mechanism of Rhododendrol-Induced Leukoderma
por: Ito, Shosuke, et al.
Publicado: (2018) -
Rhododendrol‐induced leukoderma update I: Clinical findings and treatment
por: Matsunaga, Kayoko, et al.
Publicado: (2021) -
Improvement in the quality of life of patients with rhododendrol‐induced leukoderma after camouflaging with dihydroxyacetone cream
por: Matsunaga, Kayoko, et al.
Publicado: (2020) -
Rhododendrol‐induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism‐based treatments in comparison with vitiligo
por: Inoue, Shintaro, et al.
Publicado: (2021)